These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31538558)

  • 1. Risk Factors for Carbapenem-Resistant Pseudomonas aeruginosa, Zhejiang Province, China.
    Hu YY; Cao JM; Yang Q; Chen S; Lv HY; Zhou HW; Wu Z; Zhang R
    Emerg Infect Dis; 2019 Oct; 25(10):1861-1867. PubMed ID: 31538558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of carbapenem-resistant Pseudomonas aeruginosa on clinical and economic outcomes in a Chinese tertiary care hospital: A propensity score-matched analysis.
    Chen Z; Xu Z; Wu H; Chen L; Gao S; Chen Y
    Am J Infect Control; 2019 Jun; 47(6):677-682. PubMed ID: 30554879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for healthcare-associated infection caused by carbapenem-resistant Pseudomonas aeruginosa.
    Tsao LH; Hsin CY; Liu HY; Chuang HC; Chen LY; Lee YJ
    J Microbiol Immunol Infect; 2018 Jun; 51(3):359-366. PubMed ID: 28988663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbapenem-resistant
    Huang W; Wei X; Xu G; Zhang X; Wang X
    Front Public Health; 2023; 11():1088262. PubMed ID: 36844819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for carbapenem-resistant Pseudomonas aeruginosa infection or colonization in a Chinese teaching hospital.
    Zhang D; Cui K; Wang T; Shan Y; Dong H; Feng W; Ma C; Dong Y
    J Infect Dev Ctries; 2018 Aug; 12(8):642-648. PubMed ID: 31958327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. bla
    Aruhomukama D; Najjuka CF; Kajumbula H; Okee M; Mboowa G; Sserwadda I; Mayanja R; Joloba ML; Kateete DP
    BMC Infect Dis; 2019 Oct; 19(1):853. PubMed ID: 31619192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbapenem-resistant Pseudomonas aeruginosa in Taiwan: Prevalence, risk factors, and impact on outcome of infections.
    Lin KY; Lauderdale TL; Wang JT; Chang SC
    J Microbiol Immunol Infect; 2016 Feb; 49(1):52-9. PubMed ID: 24662016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa.
    Hu Y; Qing Y; Chen J; Liu C; Lu J; Wang Q; Zhen S; Zhou H; Huang L; Zhang R
    Microbiol Spectr; 2021 Dec; 9(3):e0134421. PubMed ID: 34817230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015.
    Walters MS; Grass JE; Bulens SN; Hancock EB; Phipps EC; Muleta D; Mounsey J; Kainer MA; Concannon C; Dumyati G; Bower C; Jacob J; Cassidy PM; Beldavs Z; Culbreath K; Phillips WE; Hardy DJ; Vargas RL; Oethinger M; Ansari U; Stanton R; Albrecht V; Halpin AL; Karlsson M; Rasheed JK; Kallen A
    Emerg Infect Dis; 2019 Jul; 25(7):1281-1288. PubMed ID: 31211681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit.
    Kohlenberg A; Weitzel-Kage D; van der Linden P; Sohr D; Vögeler S; Kola A; Halle E; Rüden H; Weist K
    J Hosp Infect; 2010 Apr; 74(4):350-7. PubMed ID: 20170982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors for Pseudomonas aeruginosa infections, resistant to carbapenem].
    Ghibu L; Miftode E; Teodor A; Bejan C; Dorobăţ CM
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1012-6. PubMed ID: 21500452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant, Non-Carbapenemase-Producing Pseudomonas aeruginosa and Associated Resistance Mechanisms.
    Wi YM; Greenwood-Quaintance KE; Schuetz AN; Ko KS; Peck KR; Song JH; Patel R
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29133568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Carbapenem Resistance Mechanisms and Its Association with Pseudomonas aeruginosa Infections in the Northwest of Iran.
    Akhi MT; Khalili Y; Ghotaslou R; Yousefi S; Kafil HS; Naghili B; Sheikhalizadeh V
    Microb Drug Resist; 2018 Mar; 24(2):126-135. PubMed ID: 28654368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
    Lee CH; Su TY; Ye JJ; Hsu PC; Kuo AJ; Chia JH; Lee MH
    J Microbiol Immunol Infect; 2017 Oct; 50(5):677-683. PubMed ID: 26188977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of a hospital outbreak related to carbapenem-resistant Pseudomonas aeruginosa].
    Cekin Y; Karagöz A; Kızılateş F; Cekin AH; Oztoprak Çuvalcı N; Bülbüller N; Durmaz R
    Mikrobiyol Bul; 2013 Oct; 47(4):619-27. PubMed ID: 24237430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal Microbiota Disruption and Risk of Colonization With Carbapenem-resistant Pseudomonas aeruginosa in Intensive Care Unit Patients.
    Pettigrew MM; Gent JF; Kong Y; Halpin AL; Pineles L; Harris AD; Johnson JK
    Clin Infect Dis; 2019 Aug; 69(4):604-613. PubMed ID: 30383203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro interaction of various antibiotic combinations recommended by Chinese consensus statement against carbapenems-resistant Pseudomonas aeruginosa.
    Ma W; Li J; Wang D; Yu C; Sun S
    Lett Appl Microbiol; 2019 Sep; 69(3):198-203. PubMed ID: 31236975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Carbapenem resistance in Pseudomonas aeruginosa isolated from urine cultures: prevalence and risk factors].
    Álvarez-Otero J; Lamas-Ferreiro JL; González-González L; Rodríguez-Conde I; Fernández-Soneira MJ; Arca-Blanco A; Bermúdez-Sanjurjo JR; de la Fuente-Aguado J
    Rev Esp Quimioter; 2017 Jun; 30(3):183-194. PubMed ID: 28440605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
    Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence and Expansion of a Carbapenem-Resistant Pseudomonas aeruginosa Clone Are Associated with Plasmid-Borne
    Hu Y; Liu C; Wang Q; Zeng Y; Sun Q; Shu L; Lu J; Cai J; Wang S; Zhang R; Wu Z
    mSystems; 2021 May; 6(3):. PubMed ID: 34006625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.